Delivery Order SPE2DB22D3501-SPE2DB24FUK02
Award Date 1/30/24
Potential Completion Date 2/21/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $56,490.52 firm-fixed-price contract is for the delivery of Revlimid 10 mg capsules and has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The order, valued at $27,859.78, is for the supply of 28-count capsules of the pharmaceutical Revlimid 10 mg. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is one of multiple awards to Amerisourcebergen Drug Corp under an Indefinite Delivery Contract...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is to provide REVLIMID 25 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $107,931.18. The contract has a completion date of June 16, 2023. Amerisourcebergen Drug Corp has received numerous federal contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a firm fixed price of $178,310.12 and a period of performance through August 8, 2024. The award is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a wide range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,560 units of REVLIMID 10 MG CAPSULE 100S. The order, valued at $107,912.38, has a completion date of May 3, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was not...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REVLIMID 5 MG CAPSULE 28S pharmaceutical products. The contract has a potential value of $13,799.97 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Revlimid 25 mg capsule medication. The $20,562.98 contract has an ultimate completion date of April 24, 2024 and was awarded on April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit subsidiary of AmerisourceBergen Corporation that provides pharmaceutical products and medical supplies. The contract is a delivery order valued at $105,612.88 for the supply of 4,564,123,531 units of the prescription drug REVLIMID 10 MG CAPSULE 100S. The contract has a firm fixed price pricing type and an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp...